Registered delegates attending the Obesity & Weight Management Alliance 2026 conferences still have time to submit a poster to showcase research, innovation and best practice at the national obesity events.

Following approval from its notified body, CamDiab Ltd announces its latest innovation that will allow users to manage their type 1 diabetes without needing to count carbohydrates or give pre-meal insulin.

Scientists have made a major breakthrough in understanding why type 1 diabetes is more aggressive in young children, offering the clearest explanation to date of why the condition is particularly difficult to manage when diagnosed early in life.

The World Health Organization (WHO) today released its first global guidelines for the management of diabetes during pregnancy, a condition affecting about one in six pregnancies – or 21 million women annually.

A total of 150 delegates attended an educational event dedicated to diabetes specialist nursing earlier this year.

Tailored training on diabetes technology is needed to improve diabetes care across community and primary care settings, latest research has revealed.

The Obesity & Weight Management Alliance is delighted to unveil the speaker line-up and agenda for its 2026 UK and Ireland conference series – an essential event for healthcare professionals committed to advancing obesity care.

Researchers funded by the Type 1 Diabetes Grand Challenge have developed a new insulin–glucagon molecule, which could reduce dangerous drops in blood glucose.

The first ever immunotherapy for type 1 diabetes is critical for keeping the UK at the forefront of diabetes care, a top consultant has said.

The Obesity & Weight Management Alliance has announced a nationwide call for poster submissions ahead of its 2026 conference series, which promises to be the most extensive yet.

A unique platform that uses the universal language of music to help people better understand diabetes and other healthcare concepts has been launched to mark World Diabetes Day.  

Registrations are now open for the 2026 Obesity & Weight Management Alliance Conferences – returning for a third consecutive year with an expanded format to meet growing demand from UK healthcare professionals.

The European Association for the Study of Diabetes (EASD) is urging health systems to introduce population-wide screening for type 1 diabetes in young children, starting between ages two and four.

The digital health and medical device company behind the CamAPS FX app has announced the launch of its iPhone companion feature, enabling iPhone users to remotely monitor glucose and insulin data for people living with type 1 diabetes. 

GIRFT is inviting NHS Trusts to join a new national pilot designed to improve insulin management for people living with diabetes in the community, while also creating a more efficient service for the NHS.

GLP-1 receptor agonist drugs protect against diabetic retinopathy – a common complication of diabetes that can lead to sight loss.

A new synthesis of global evidence finds that experiencing gestational diabetes during pregnancy is linked with a decline in intellectual function among mothers, and may increase the risk of autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD) in children. 

In adults with type 1 diabetes and obesity, low dose tirzepatide reduced their weight, HbA1c levels and insulin dose requirements, a clinical trial has demonstrated.